Contamination Source Identification
Contamination Source Identification operates a CLIA-certified laboratory that develops and runs an untargeted, RNA-focused next-generation sequencing diagnostic platform to identify active bacterial, viral, and eukaryotic pathogens directly from clinical specimens. The organization combines automated wet-lab processing, high-throughput sequencing, proprietary sample-preparation methods, and a rapid bioinformatics analysis and reporting pipeline to provide clinicians actionable results (including antimicrobial resistance information) with rapid turnaround times for applications such as neonatal sepsis and prosthetic joint infection.
Industries
Nr. of Employees
small (1-50)
Contamination Source Identification
Products
Untargeted RNA-based pathogen detection assay
An untargeted clinical assay that isolates and sequences microbial RNA from clinical specimens to identify active bacterial, viral, and eukaryotic pathogens and provide functional expression context.
Untargeted RNA-based pathogen detection assay
An untargeted clinical assay that isolates and sequences microbial RNA from clinical specimens to identify active bacterial, viral, and eukaryotic pathogens and provide functional expression context.
Services
Clinical laboratory testing service that performs untargeted RNA-based NGS to detect active pathogenic microbes and report taxonomic identification and resistance markers to clinicians.
Rapid analysis and clinical reporting service that processes sequencing data, performs taxonomic and resistance analyses, and delivers clinician-facing reports.
Provision of standardized sample kits and automated laboratory processing to support scalable clinical sample intake and sequencing.
Clinical laboratory testing service that performs untargeted RNA-based NGS to detect active pathogenic microbes and report taxonomic identification and resistance markers to clinicians.
Rapid analysis and clinical reporting service that processes sequencing data, performs taxonomic and resistance analyses, and delivers clinician-facing reports.
Provision of standardized sample kits and automated laboratory processing to support scalable clinical sample intake and sequencing.
Expertise Areas
- Metatranscriptomic and metagenomic diagnostics
- Clinical diagnostic development for sepsis and prosthetic joint infection
- Neonatal and pediatric sepsis diagnostics
- Bioinformatics pipeline development and clinical reporting
Key Technologies
- Next-generation sequencing (NGS)
- Metatranscriptomics (RNA sequencing)
- Metagenomics (DNA sequencing)
- 16S rRNA gene sequencing
News & Updates
Peer-reviewed publication describing metatranscriptomic application for detecting pathogens in prosthetic joint infection samples.
Peer-reviewed comparative meta-omics study evaluating methods to identify pathogens in prosthetic joint infections.
Peer-reviewed metatranscriptomics study surveying microbial diversity on surfaces after cleaning interventions.
Peer-reviewed evaluation of a continuous cleaning device using metatranscriptomic methods.
Peer-reviewed study reporting reduced microbial activity on surfaces after a cleaning intervention.
Peer-reviewed publication describing metatranscriptomic application for detecting pathogens in prosthetic joint infection samples.
Peer-reviewed comparative meta-omics study evaluating methods to identify pathogens in prosthetic joint infections.
Peer-reviewed metatranscriptomics study surveying microbial diversity on surfaces after cleaning interventions.
Peer-reviewed evaluation of a continuous cleaning device using metatranscriptomic methods.
Peer-reviewed study reporting reduced microbial activity on surfaces after a cleaning intervention.